HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mandip Singh Selected Research

Vimentin

11/2019Withaferin A reverses bile duct ligation-induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signaling.
7/2016Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.
4/2015Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
1/2014CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mandip Singh Research Topics

Disease

50Neoplasms (Cancer)
10/2023 - 02/2004
18Lung Neoplasms (Lung Cancer)
01/2024 - 09/2006
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 09/2006
13Triple Negative Breast Neoplasms
11/2022 - 03/2011
10Inflammation (Inflammations)
04/2023 - 01/2004
8Neoplasm Metastasis (Metastasis)
09/2021 - 05/2013
6Skin Neoplasms (Skin Cancer)
06/2019 - 01/2013
5Breast Neoplasms (Breast Cancer)
10/2018 - 01/2014
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017 - 01/2004
3Neuralgia (Stump Neuralgia)
10/2023 - 06/2022
3Peripheral Nervous System Diseases (PNS Diseases)
08/2023 - 06/2022
3Weight Loss (Weight Reduction)
09/2015 - 11/2010
2Nervous System Diseases (Neurological Disorders)
07/2023 - 01/2016
2Hyperplasia
01/2017 - 07/2016
2Cardiovascular Diseases (Cardiovascular Disease)
03/2016 - 01/2016
2Allergic Contact Dermatitis
10/2005 - 01/2004
2Contact Dermatitis (Eczema, Contact)
01/2004 - 01/2004
1Chronic Pain
02/2024
1Alzheimer Disease (Alzheimer's Disease)
07/2023
1Multiple Sclerosis
07/2023
1Ischemic Stroke
07/2023
1Pain (Aches)
02/2023
1Macular Degeneration (Age-Related Maculopathy)
10/2022
1Retinitis Pigmentosa (Pigmentary Retinopathy)
10/2022
1Diabetic Retinopathy (Retinopathy, Diabetic)
10/2022
1Stargardt Disease
10/2022
1Edema (Dropsy)
08/2022
1Ganglion Cysts (Ganglion)
06/2022
1Adenocarcinoma of Lung
11/2021

Drug/Important Bio-Agent (IBA)

16Docetaxel (Taxotere)FDA Link
11/2021 - 01/2006
13Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2007
11Liposomes (Liposome)IBA
01/2020 - 06/2003
8Doxorubicin (Adriamycin)FDA LinkGeneric
05/2023 - 03/2011
7CannabidiolIBA
08/2023 - 09/2021
7Telmisartan (Micardis)FDA Link
05/2022 - 11/2013
7LipidsIBA
01/2021 - 05/2013
6Cisplatin (Platino)FDA LinkGeneric
02/2021 - 03/2011
6Noscapine (Narcotine)IBA
11/2017 - 12/2008
5Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2021 - 01/2017
5Small Interfering RNA (siRNA)IBA
01/2019 - 08/2013
5SolutionsIBA
10/2018 - 09/2006
5Caspase 3 (Caspase-3)IBA
01/2014 - 09/2006
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 01/2006
4Tyrosine Kinase InhibitorsIBA
05/2022 - 07/2018
4ErbB Receptors (EGF Receptor)IBA
05/2022 - 10/2015
4VimentinIBA
11/2019 - 01/2014
43,3'-diindolylmethane (diindolylmethane)IBA
11/2016 - 01/2009
4Peptides (Polypeptides)IBA
01/2016 - 01/2004
4SurvivinIBA
10/2015 - 11/2010
4Messenger RNA (mRNA)IBA
01/2014 - 09/2006
4PPAR gammaIBA
01/2009 - 02/2004
3osimertinibIBA
01/2024 - 01/2021
3Paclitaxel (Taxol)FDA LinkGeneric
08/2023 - 06/2022
3RNA (Ribonucleic Acid)IBA
06/2022 - 06/2014
3HydrogelsIBA
11/2021 - 12/2019
3CateninsIBA
12/2019 - 10/2013
3LigandsIBA
05/2016 - 10/2015
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2016 - 10/2015
3CollagenIBA
01/2016 - 01/2016
3Celecoxib (Celebrex)FDA Link
05/2013 - 01/2006
3spantide IIIBA
10/2005 - 01/2004
2CannabinoidsIBA
10/2023 - 08/2022
2Polysaccharides (Glycans)IBA
11/2021 - 01/2020
2rociletinibIBA
09/2021 - 07/2018
2Sorafenib (BAY 43-9006)FDA Link
09/2021 - 07/2018
2AlginatesIBA
12/2019 - 01/2016
2withaferin AIBA
11/2019 - 09/2019
2Sunscreening Agents (Sunscreens)IBA
06/2019 - 07/2016
2Tacrolimus (Prograf)FDA LinkGeneric
04/2018 - 01/2017
2IntegrinsIBA
04/2018 - 05/2016
2Cholecalciferol (Vitamin D3)FDA Link
04/2018 - 02/2018
2Phosphotransferases (Kinase)IBA
11/2017 - 11/2010
2GemcitabineFDA Link
01/2017 - 01/2011
2Imiquimod (Aldara)FDA LinkGeneric
01/2017 - 01/2016
2Proliferating Cell Nuclear Antigen (PCNA)IBA
07/2016 - 01/2016
21,1- bis(3'- indolyl)- 1- (4- hydroxyphenyl)methaneIBA
05/2016 - 05/2016
2Orphan Nuclear ReceptorsIBA
10/2015 - 01/2013
2Antineoplastic Agents (Antineoplastics)IBA
10/2014 - 01/2013
21,1- bis(3'- indolyl)- 1- (4- biphenyl)methaneIBA
10/2014 - 07/2014
2Cyclin D1IBA
01/2014 - 11/2010
2AerosolsIBA
11/2010 - 09/2006
2Dinoprostone (PGE2)FDA Link
09/2006 - 01/2006
2EnzymesIBA
09/2006 - 02/2004
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2006 - 02/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2006 - 02/2004
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2004 - 01/2004
2Substance PIBA
01/2004 - 01/2004
1Nerve Growth Factors (Neurotrophins)IBA
02/2024
1Carboplatin (JM8)FDA LinkGeneric
01/2024
1Interleukin-15 (Interleukin 15)IBA
01/2024
1Amyloid beta-PeptidesIBA
04/2023
1Interleukin-6 (Interleukin 6)IBA
04/2023
1Retinaldehyde (Retinal)IBA
10/2022
1Calcium Gluconate (CBG)IBA
08/2022
1cannabigerolIBA
08/2022
1Apoptosis Regulatory ProteinsIBA
05/2022

Therapy/Procedure

14Therapeutics
07/2023 - 05/2013
7Drug Therapy (Chemotherapy)
10/2023 - 01/2011
6Chemoprevention
06/2019 - 01/2013
4Oral Administration
11/2017 - 12/2008